CIBC Private Wealth Group
TGTX icon

CIBC Private Wealth Group’s TG Therapeutics TGTX Stock Holding History

CIBC Private Wealth Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.59K Buy
221
+24
+12% +$784 ﹤0.01% 2559
2025
Q3 		$7.12K Sell
197
-693
-78% -$22.8K ﹤0.01% 2492
2025
Q2 		$32K Buy
890
+1
+0.1% +$37 ﹤0.01% 1839
2025
Q1 		$31.6K Sell
889
-300
-25% -$10.1K ﹤0.01% 1803
2024
Q4 		$34.2K Sell
1,189
-250
-17% -$7.17K ﹤0.01% 1832
2024
Q3 		$33.7K Sell
1,439
-250
-15% -$5.46K ﹤0.01% 1921
2024
Q2 		$33K Buy
1,689
+1,000
+145% +$16K ﹤0.01% 1837
2024
Q1 		$10.2K Buy
+689
New +$11K ﹤0.01% 2266
2018
Q3 		– Sell
-1,800
Closed -$24K – 1651
2018
Q2 		$24K Buy
1,800
+1,200
+200% +$16.5K ﹤0.01% 1357
2018
Q1 		$9K Buy
+600
New +$7.67K ﹤0.01% 1561

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CIBC Private Wealth Group's TGTX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its TG Therapeutics (TGTX) stake by 12% in Q4 2025, buying an estimated $784 and bringing the position to 221 shares worth $6.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

CIBC Private Wealth Group first reported a position in TGTX in Q1 2018 and has held it in 10 quarters since. The position peaked at $34.2K in Q4 2024. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • CIBC Private Wealth Group held 221 shares of TG Therapeutics worth $6.59K as of Q4 2025.
  • CIBC Private Wealth Group bought 24 TG Therapeutics shares in Q4 2025, an estimated $784.
  • TG Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2559 holding.
  • CIBC Private Wealth Group first reported a position in TG Therapeutics in Q1 2018 and has held it in 10 quarters since.
  • CIBC Private Wealth Group's TG Therapeutics position peaked at $34.2K in Q4 2024.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.